Loading stock data…
$1.18
Vivani Medical, Inc., a clinical-stage biopharmaceutical company, engages in the development of miniaturized and subdermal drug implants that treat chronic diseases.
Vivani Medical, Inc. in the Healthcare sector is trading at $1.18 with a market capitalization of $106M. Wall Street consensus targets $3.83 (3 analysts), implying a +224.9% move over the next 12 months. The stock is currently 39% below its 52-week high of $1.92, remaining 7.1% below its 200-day moving average. On fundamentals, Piotroski 2/9 flags weak fundamentals, Altman Z in the distress zone. Risk note: MACD remains below its signal line. The Whystock Score of 45/100 suggests a balanced risk-reward profile.
| Metric (USD) | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|---|
| Total Revenue | $0 | $0 | $0 | $0 | $0 |
| Gross Profit | — | — | — | — | — |
| Operating Income | -$6.87M↓ | -$6.82M↓ | -$6.81M↓ | -$6.72M↑ | -$7.46M |
| Net Income | -$6.37M↑ | -$6.78M↓ | -$6.63M↓ | -$6.53M↑ | -$7.14M |
Vivani Medical, Inc., a clinical-stage biopharmaceutical company, engages in the development of miniaturized and subdermal drug implants that treat chronic diseases. The company uses its NanoPortal implant technology to develop and potentially commer...